Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,646 public trials 848 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Recruiting

A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma

NCT04669171

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • University of Rochester Medical Center (URMC) - Wilmot Cancer Institute (WCI) (James P. Wilmot Cancer Center) Rochester, New York, United States
  • University of Washington-Seattle Cancer Care Alliance Seattle, Washington, United States
View Trial Details
Recruiting

Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients

NCT05300282

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations
  • S.C. Ematologia - A.O. SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy
  • Ematologia - Fondazione del Piemonte per l'Oncologia - IRCCS Candiolo, Turin, Italy
  • S.C. Ematologia e Trapianto emopoietico - Azienda Ospedaliera S.Giuseppe Moscati Avellino, Italy
  • Divisione di Oncologia e dei Tumori immuto-correlati - IRCCS Centro di Riferimento Oncologico di Aviano Aviano, Italy
View all 32 locations
View Trial Details
Recruiting

Study of AXT-1003 in Subjects With Advanced Malignant Tumors.

NCT06484985

Conditions
Advanced Solid Tumor, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • Hunan Cancer Hosptial Changsha, China
  • Fujian Cancer Hospital Fuzhou, China
  • Sun Yat-Sen University Cancer Center Guangzhou, China
View Trial Details
Recruiting

Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy

NCT06834373

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +39 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Mayo Clinic Health System in Albert Lea Albert Lea, Minnesota, United States
  • Mayo Clinic Health Systems-Mankato Mankato, Minnesota, United States
View Trial Details

Related conditions